{"doi":"10.1101/2023.01.27.525867","title":"Dysregulated CD38 expression in blood and skin immune cells of patients with hidradenitis suppurativa","abstract":"Background: Hidradenitis suppurativa (HS) is a multifactorial, inflammatory skin disease. Increased systemic inflammatory comorbidities and serum cytokines highlight systemic inflammation as a feature of HS. However, the specific immune cell subsets contributing to systemic and cutaneous inflammation have not been resolved. Objective: Identify features of peripheral and cutaneous immune dysregulation. Methods: Here, we generated whole-blood immunomes by mass cytometry. We performed a meta-analysis of RNA-seq data, immunohistochemistry, and imaging mass cytometry to characterize the immunological landscape of skin lesions and perilesions from patients with HS. Results: Blood from patients with HS exhibited lower frequencies of natural killer cells, dendritic cells, and classical (CD14+CD16-) and nonclassical (CD14-CD16+) monocytes, as well as higher frequencies of Th17 cells and intermediate (CD14+CD16+) monocytes than blood from healthy controls. Classical and intermediate monocytes from patients with HS had increased expression of skin-homing chemokine receptors. Furthermore, we identified a CD38+ intermediate monocyte subpopulation that was more abundant in the immunome of blood from patients with HS. Meta-analysis of RNA-seq data found higher CD38 expression in lesional HS skin than in perilesional skin, and markers of classical monocyte infiltration. Imaging mass cytometry showed that CD38+ classical monocytes and CD38+ monocyte-derived macrophages were more abundant in lesional HS skin. Conclusion: Overall, we report targeting CD38 may be worth pursuing in clinical trials. Key Messages: 3.Monocyte subsets express markers of activation in circulation and HS lesionsTargeting CD38 may be a viable strategy for treating systemic and cutaneous inflammation in patients with HS. Capsule Summary: 4.Dysregulated immune cells in patients with HS express CD38 and may be targeting by anti-CD38 immunotherapy.","journal":"bioRxiv (Cold Spring Harbor Laboratory)","year":2023,"id":398315,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":1,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9658,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2023-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":523743,"name":"Iltefat Hamzavi","orcid":"0000-0002-3137-5601","position":1,"is_corresponding":false},{"id":334891,"name":"Congcong Yin","orcid":"0000-0003-0865-2823","position":2,"is_corresponding":false},{"id":923829,"name":"Ian M. Loveless","orcid":"0000-0003-4645-6559","position":3,"is_corresponding":false},{"id":314923,"name":"Jugmohit Toor","orcid":"0000-0002-8796-8799","position":4,"is_corresponding":false},{"id":670385,"name":"Kalpana Subedi","orcid":"0000-0002-1808-3268","position":5,"is_corresponding":false},{"id":335841,"name":"Namir Khalasawi","orcid":null,"position":6,"is_corresponding":false},{"id":972173,"name":"Angela Miller","orcid":"0009-0008-8684-1703","position":7,"is_corresponding":false},{"id":1129690,"name":"Richard H. Huggins","orcid":null,"position":8,"is_corresponding":false},{"id":274753,"name":"Indra Adrianto","orcid":"0000-0002-9973-3057","position":9,"is_corresponding":false},{"id":886968,"name":"Jesse Veenstra","orcid":"0000-0002-3576-855X","position":10,"is_corresponding":false},{"id":674028,"name":"Gautham Vellaichamy","orcid":"0000-0003-2345-8914","position":11,"is_corresponding":false},{"id":1129275,"name":"Aakash Hans","orcid":"0000-0003-0761-8551","position":12,"is_corresponding":false},{"id":1129276,"name":"Steven Daveluy","orcid":"0000-0002-6951-2894","position":13,"is_corresponding":false},{"id":259115,"name":"Mohammad Athar","orcid":"0000-0001-5829-7992","position":14,"is_corresponding":false},{"id":94228,"name":"Wilson Liao","orcid":"0000-0001-7883-6439","position":15,"is_corresponding":false},{"id":621868,"name":"Henry W. Lim","orcid":"0000-0002-1576-1115","position":16,"is_corresponding":false},{"id":674029,"name":"David Ozog","orcid":"0000-0001-8479-6736","position":17,"is_corresponding":false},{"id":334894,"name":"Li Zhou","orcid":"0000-0002-7028-3865","position":18,"is_corresponding":false},{"id":242437,"name":"Qing‐Sheng Mi","orcid":"0000-0002-1411-6827","position":19,"is_corresponding":false},{"id":655073,"name":"Peter Dimitrion","orcid":"0000-0002-5648-5962","position":0,"is_corresponding":true}],"reference_count":57,"raw_metadata":null,"created_at":"2026-07-19T01:19:43.776284Z","pmid":"36891290","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}